ICMR exploring saliva-based tests to diagnose Covid-19: Harsh Vardhan

Vardhan also said that no significant or drastic mutations had been found in strains of SARS-CoV-2 in India till now

coronavirus
He added that detailed results on mutations and evolution of the virus would be available in early October.
Ruchika Chitravanshi New Delhi
2 min read Last Updated : Sep 20 2020 | 6:28 PM IST
The Indian Council of Medical Research (ICMR) is exploring the saliva based test method for Covid-19 and while it has validated a few tests, it has not found any to be reliable, Harsh Vardhan, health and family welfare minister said on Sunday.

The minister, while addressing a social media dialogue, said that companies with tests approved by the USFDA had still not approached the Indian government.


 
Vardhan also said that no significant or drastic mutations had been found in strains of SARS-CoV-2 in India till now. He said that ICMR had been conducting large-scale sequencing of nationally representative strains of the coronavirus collected over the past several months over different time-points. He added that detailed results on mutations and evolution of the virus would be available in early October.

The health minister said that the government had dispatched oxygen concentrators to the rural parts of the country to “avert the logistic issues coming to light.”
 
Speaking on the issue of restarting the Oxford-AstraZeneca vaccine trial, Vardhan  said, “The trials have been restarted only after an independent investigative expert committee gave them the permission to proceed ahead.”

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus TestsICMRHarsh VardhanUSFDAAstraZenecaCoronavirus Vaccine

Next Story